The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.

Nikki Adler, Linda Graudins, Ar Kar Aung

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Pages (from-to)1461
JournalBritish Journal of Dermatology
Volume177
Issue number5
DOIs
Publication statusPublished - 2017

Cite this

@article{a244dc3beba344148ada6f5c9a83027d,
title = "The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.",
author = "Nikki Adler and Linda Graudins and Aung, {Ar Kar}",
year = "2017",
doi = "10.1111/bjd.15737",
language = "English",
volume = "177",
pages = "1461",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "5",

}

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions. / Adler, Nikki; Graudins, Linda; Aung, Ar Kar.

In: British Journal of Dermatology, Vol. 177, No. 5, 2017, p. 1461.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.

AU - Adler, Nikki

AU - Graudins, Linda

AU - Aung, Ar Kar

PY - 2017

Y1 - 2017

U2 - 10.1111/bjd.15737

DO - 10.1111/bjd.15737

M3 - Letter

VL - 177

SP - 1461

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 5

ER -